Published in Clin Biochem on October 01, 2004
Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One (2010) 2.52
Use of Estrogen-Containing Contraception Is Associated With Increased Concentrations of 25-Hydroxy Vitamin D. J Clin Endocrinol Metab (2016) 2.21
Vitamin D deficiency in pregnancy and gestational diabetes mellitus. Am J Obstet Gynecol (2012) 1.93
Vitamin D deficiency, smoking, and lung function in the Normative Aging Study. Am J Respir Crit Care Med (2012) 1.75
High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J Pediatr (2010) 1.68
Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study. J Am Soc Nephrol (2015) 1.47
Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr (2015) 1.44
Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults. Am J Epidemiol (2012) 1.34
Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res (2009) 1.33
Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2010) 1.30
Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants. Ann Epidemiol (2012) 1.24
Serum vitamin D and risk of bladder cancer. Cancer Res (2010) 1.17
Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.12
Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr (2011) 1.12
Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr (2010) 1.12
Prevalence and correlates of vitamin D status in African American men. BMC Public Health (2009) 1.10
Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int (2009) 1.08
The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going. J Steroid Biochem Mol Biol (2007) 1.07
Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol (2013) 1.05
Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer (2012) 1.02
The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp Clin Trials (2014) 1.02
Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J (2011) 1.01
Ethnic-specific differences in vitamin D status is associated with adiposity. PLoS One (2012) 1.00
Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. Int J Womens Health (2013) 1.00
Improving the measurement of 25-hydroxyvitamin D. Clin Biochem Rev (2005) 1.00
Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am (2010) 0.98
Vitamin D in African Americans with multiple sclerosis. Neurology (2011) 0.98
Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br J Nutr (2012) 0.97
Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS One (2012) 0.96
Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsis. PLoS One (2013) 0.96
Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int (2009) 0.95
Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr (2014) 0.93
The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. J Allergy Clin Immunol (2014) 0.93
25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings. J Infect Dis (2014) 0.92
Serum 25(OH)D, PTH and correlates of suboptimal 25(OH)D levels in persons with chronic spinal cord injury. Spinal Cord (2012) 0.92
Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Int J Cancer (2014) 0.89
Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J (2010) 0.89
Prevalence of vitamin D deficiency during the summer and its relationship with sun exposure and skin phototype in elderly men living in the tropics. Clin Interv Aging (2013) 0.89
Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One (2014) 0.89
Vitamin D status among preterm and full-term infants at birth. Pediatr Res (2013) 0.88
Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol (2011) 0.88
Use of a questionnaire to assess vitamin D status in young adults. Public Health Nutr (2008) 0.88
1,25-Dihydroxyvitamin D deficiency is associated with preterm birth in African American and Caucasian women. Reprod Sci (2013) 0.87
Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med (2012) 0.87
A prospective study of serum 25-hydroxyvitamin d levels and mortality among African Americans and non-African Americans. Am J Epidemiol (2012) 0.86
Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis (2012) 0.85
Effects of vitamin D insufficiency on bone mineral density in African American men. Osteoporos Int (2008) 0.85
The impact of delayed blood centrifuging, choice of collection tube, and type of assay on 25-hydroxyvitamin D concentrations. Cancer Causes Control (2009) 0.85
Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk. Vasc Health Risk Manag (2013) 0.85
Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival. Cancer Epidemiol Biomarkers Prev (2016) 0.84
Plasma vitamin D biomarkers and leukocyte telomere length. Am J Epidemiol (2013) 0.84
Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study. J Investig Med (2011) 0.84
High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome. Arch Dermatol (2010) 0.84
Vitamin D status and hypertensive disorders in pregnancy. Ann Epidemiol (2014) 0.83
Lower-extremity muscle atrophy and fat infiltration after chronic spinal cord injury. J Musculoskelet Neuronal Interact (2015) 0.82
The association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer. PLoS One (2015) 0.82
The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther (2013) 0.82
Vitamin D deficiency is independently associated with mortality among critically ill patients. Clinics (Sao Paulo) (2015) 0.82
Serum vitamin D, vitamin D binding protein, and lung cancer survival. Lung Cancer (2014) 0.82
An initial loading-dose vitamin D versus placebo after hip fracture surgery: baseline characteristics of a randomized controlled trial (REVITAHIP). BMC Geriatr (2014) 0.81
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer. BMC Cancer (2015) 0.81
25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst (2014) 0.81
Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona. BMC Med Genet (2013) 0.81
Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort. Pediatr Nephrol (2015) 0.80
Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. J Nutr (2014) 0.80
Correlates of 25-hydroxyvitamin D and breast cancer stage in the Women's Healthy Eating and Living Study. Nutr Cancer (2013) 0.80
Digestive efficiency mediated by serum calcium predicts bone mineral density in the common marmoset (Callithrix jacchus). Am J Primatol (2012) 0.80
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol (2016) 0.80
Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection. Vasc Health Risk Manag (2013) 0.80
Vitamin D safety and requirements. Arch Biochem Biophys (2011) 0.79
Vitamin D status, functional decline, and mortality in peripheral artery disease. Vasc Med (2014) 0.79
Impact of vitamin D3 dietary supplement matrix on clinical response. J Clin Endocrinol Metab (2014) 0.78
Lower prenatal vitamin D status and postpartum depressive symptomatology in African American women: Preliminary evidence for moderation by inflammatory cytokines. Arch Womens Ment Health (2015) 0.77
Association between vitamin D status and serum parathyroid hormone concentration and calcaneal stiffness in Japanese adolescents: sex differences in susceptibility to vitamin D deficiency. J Bone Miner Metab (2015) 0.77
Effects of Vitamin D3 Supplementation on Lean Mass, Muscle Strength, and Bone Mineral Density During Weight Loss: A Double-Blind Randomized Controlled Trial. J Am Geriatr Soc (2016) 0.77
The "Got D'ViBE?" study: an inter-institutional project assessing vitamin D and mammographic breast density. J Health Care Poor Underserved (2010) 0.77
Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. Cancer Res (2016) 0.77
Prenatal, perinatal, and childhood vitamin D exposure and their association with childhood allergic rhinitis and allergic sensitization. J Allergy Clin Immunol (2016) 0.76
Prenatal vitamin use and vitamin D status during pregnancy, differences by race and overweight status. J Perinatol (2014) 0.76
Evaluation of markers of bone turnover during lactation in African-Americans: a comparison with Caucasian lactation. J Clin Endocrinol Metab (2012) 0.76
Vitamin D and bronchopulmonary dysplasia in preterm infants. J Perinatol (2016) 0.75
Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women. Fertil Steril (2016) 0.75
Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women. Nutr Res (2015) 0.75
The association between vitamin D receptor gene polymorphisms (TaqI and FokI), Type 2 diabetes, and micro-/macrovascular complications in postmenopausal women. Appl Clin Genet (2016) 0.75
An initial loading-dose vitamin D versus placebo after hip fracture surgery: randomized trial. BMC Musculoskelet Disord (2016) 0.75
Effects of a parallel-arm randomized controlled weight loss pilot study on biological and psychosocial parameters of overweight and obese breast cancer survivors. Pilot Feasibility Stud (2017) 0.75
Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism. Vasc Health Risk Manag (2017) 0.75
Total and free circulating vitamin D and vitamin D binding protein in relation to colorectal cancer risk in a prospective study of African Americans. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Vitamin D prenatal programming of childhood metabolomics profiles at age 3 y. Am J Clin Nutr (2017) 0.75
Metabolome alterations in severe critical illness and vitamin D status. Crit Care (2017) 0.75
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol (2010) 9.29
Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab (2004) 8.36
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. J Clin Oncol (2009) 3.37
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am (2013) 2.29
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases. J Clin Oncol (2007) 2.24
A retrospective analysis of vertebral body fractures following epidural steroid injections. J Bone Joint Surg Am (2013) 1.48
Abnormal bone remodeling in patients with spontaneous painful vertebral fracture. J Bone Miner Res (2011) 1.42
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial. J Clin Endocrinol Metab (2012) 1.38
Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin North Am (2010) 1.32
Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.14
Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol (2009) 1.14
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis (2006) 1.09
Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int (2007) 1.06
Severe vitamin D deficiency in Arab-American women living in Dearborn, Michigan. Endocr Pract (2009) 1.03
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies. Cancer Treat Rev (2008) 1.03
Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. Breast Cancer Res Treat (2007) 1.02
Consensus on the utility of bone markers in the malignant bone disease setting. Crit Rev Oncol Hematol (2011) 1.01
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference. Clin Cancer Res (2008) 1.00
The morphological association between microcracks and osteocyte lacunae in human cortical bone. Bone (2005) 0.99
Analytical and clinical validation of a radioimmunoassay for the measurement of 1,25 dihydroxy vitamin D. Clin Biochem (2002) 0.99
Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study. J Clin Oncol (2004) 0.99
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer (2012) 0.99
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.99
Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res (2003) 0.95
Successful use of ketamine for intractable cancer pain. Support Care Cancer (2004) 0.95
Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients. Breast Cancer Res Treat (2008) 0.95
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC Cancer (2010) 0.95
The demographics of suspected deep tissue injury in the United States: an analysis of the International Pressure Ulcer Prevalence Survey 2006-2009. Adv Skin Wound Care (2010) 0.94
Osteomalacia as a result of vitamin D deficiency. Rheum Dis Clin North Am (2012) 0.93
Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology (2011) 0.92
Differences in osteocyte and lacunar density between Black and White American women. Bone (2005) 0.91
Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone (2009) 0.91
Vitamin D nutritional status and antenatal depressive symptoms in African American women. J Womens Health (Larchmt) (2012) 0.90
Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis (2008) 0.90
Patient preferences for treatments to delay bone metastases. Prostate (2014) 0.89
Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort. Arch Dermatol (2011) 0.89
Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer. J Clin Oncol (2009) 0.88
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom. Support Care Cancer (2014) 0.88
Histomorphometric assessment of Haversian canal and osteocyte lacunae in different-sized osteons in human rib. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.88
Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87
Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells. Eur Urol (2004) 0.87
Reducing the burden of bone metastases: current concepts and treatment options. Support Care Cancer (2013) 0.86
Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol (2005) 0.85
Health technology assessment in osteoporosis. Calcif Tissue Int (2013) 0.85
Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone (2011) 0.84
Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Calcif Tissue Int (2009) 0.84
Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas. Clin Endocrinol (Oxf) (2008) 0.84
PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor. Bone (2006) 0.84
Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. Endocr Pract (2009) 0.84
Preventing vitamin D toxicity in patients with sarcoidosis. J Am Acad Dermatol (2011) 0.83
Relating micromechanical properties and mineral densities in severely suppressed bone turnover patients, osteoporotic patients, and normal subjects. Bone (2012) 0.83
Dependence of bone yield (volume of bone formed per unit of cement surface area) on resorption cavity size during osteonal remodeling in human rib: implications for osteoblast function and the pathogenesis of age-related bone loss. J Bone Miner Res (2010) 0.83
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.83
Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways. Mol Cell Endocrinol (2004) 0.83
Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials. Clin Ther (2004) 0.83
Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis (2006) 0.83
Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem (2008) 0.82
Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women. Spine (Phila Pa 1976) (2012) 0.82
Independent and combined contributions of cancellous and cortical bone deficits to vertebral fracture risk in postmenopausal women. J Bone Miner Res (2006) 0.82
Health state utilities for skeletal-related events secondary to bone metastases. Eur J Health Econ (2013) 0.82
Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism. Endocr Pract (2008) 0.81
Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass. Am J Surg (2008) 0.81
Psychosocial rehabilitation of cancer patients after curative therapy. Support Care Cancer (2001) 0.81
Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial. Clin Drug Investig (2006) 0.81
Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference. Clin Cancer Res (2006) 0.80
Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma. Breast Cancer Res Treat (2004) 0.80
CXCL5 stimulation of RANK ligand expression in Paget's disease of bone. Lab Invest (2013) 0.79
Ibandronate in metastatic bone disease: a review of preclinical data. Anticancer Drugs (2005) 0.79
Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells. Breast Cancer Res (2008) 0.79
Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health. Expert Opin Drug Saf (2008) 0.79
FGF-2 stimulation of RANK ligand expression in Paget's disease of bone. Mol Endocrinol (2009) 0.78
Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines. Breast Cancer Res (2005) 0.78
Images in clinical medicine. Tumor-induced osteomalacia. N Engl J Med (2008) 0.77
Ibandronate in metastatic bone pain. Semin Oncol (2004) 0.76
Elevated serum kininogen in patients with Paget's disease of bone: a role in marrow stromal/preosteoblast cell proliferation. J Cell Biochem (2006) 0.76
Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments. Breast Cancer Res (2003) 0.76
Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia. J Clin Endocrinol Metab (2013) 0.76
Hyperparathyroidism-jaw tumor syndrome. Endocr Pract (2009) 0.75
Post-operative partial hypoparathyroidism: an under-recognized disorder (Re: ANZ J. Surg. 2011; 81: 524-7). ANZ J Surg (2012) 0.75
Bisphosphonate safety and tolerability. Oncologist (2005) 0.75
Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease. Eur J Epidemiol (2003) 0.75
Continuous lateral rotation therapy for acute hypoxemic respiratory failure: the effect of timing. Dimens Crit Care Nurs (2009) 0.75
Visual vignette. Endocr Pract (2010) 0.75
Ibandronate reduces skeletal morbidity in patients with breast cancer. Semin Oncol (2004) 0.75
Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: cure after bilateral adrenalectomy. Calcif Tissue Int (2011) 0.75
Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines. Clin Exp Metastasis (2006) 0.75
The effect of endogenous parathyroid hormone in iliac bone structure and turnover in healthy postmenopausal women. Calcif Tissue Int (2013) 0.75